Digital Health Market by Offering (Hardware(Wearables, Implants), Apps (Telehealth (RPM), DTx, Patient Portals, Pharmacy)), Disease (Diabetes, CVS, Mental Health), Use Case (Treatment, Monitoring, Rehab & Recovery), End User, and Region - Global Forecast to 2030

1 INTRODUCTION 37 1.1 STUDY OBJECTIVES 37 1.2 MARKET DEFINITION 37 1.3 MARKET SCOPE 38 1.3.1 MARKETS COVERED AND REGIONS CONSIDERED 38 1.3.2 INCLUSIONS & EXCLUSIONS 39 1.3.3 YEARS CONSIDERED 40 1.3.4 CURRENCY CONSIDERED 40 1.4 STAKEHOLDERS 41 1.5 SUMMARY OF CHANGES 41 2 RESEARCH METHODOLOGY 43 2.1 RESEARCH DATA 43 2.1.1 SECONDARY DATA 44 2.1.1.1 Key data from secondary sources 45 2.1.2 PRIMARY DATA 45 2.1.2.1 Key data from primary interviews 47 2.1.2.2 Insights from primary experts 47 2.1.2.3 Breakdown of primary sources 48 2.2 RESEARCH METHODOLOGY 48 2.3 MARKET SIZE ESTIMATION 49 2.4 DATA TRIANGULATION 58 2.5 MARKET RANKING ANALYSIS 59 2.6 RISK ASSESSMENT 59 2.7 STUDY ASSUMPTIONS 59 2.8 LIMITATIONS 60 2.8.1 METHODOLOGY-RELATED LIMITATIONS 60 2.8.2 SCOPE-RELATED LIMITATIONS 60 3 EXECUTIVE SUMMARY 61 4 PREMIUM INSIGHTS 66 4.1 DIGITAL HEALTH MARKET OVERVIEW 66 4.2 NORTH AMERICA: DIGITAL HEALTH MARKET, BY END USER AND COUNTRY 67 4.3 DIGITAL HEALTH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68 4.4 DIGITAL HEALTH MARKET: REGIONAL MIX 69 4.5 DIGITAL HEALTH MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 69   5 MARKET OVERVIEW 70 5.1 INTRODUCTION 70 5.2 MARKET DYNAMICS 70 5.2.1 DRIVERS 71 5.2.1.1 Increasing penetration of smartphones, tablets, and other mobile platforms 71 5.2.1.2 Rising geriatric population and subsequent increase in prevalence of chronic diseases 71 5.2.1.3 Rising focus on patient-centric healthcare solutions 72 5.2.1.4 Rising use of wearables 73 5.2.1.5 Advancements in AI, sensors, and connectivity (5G and 6G) 73 5.2.1.6 Growth of AI-powered virtual assistants and chatbots 74 5.2.2 RESTRAINTS 74 5.2.2.1 Low digital literacy in certain demographics 74 5.2.2.2 Interoperability issues 75 5.2.3 OPPORTUNITIES 75 5.2.3.1 Shift toward intelligent health ecosystem to deliver personalized health experiences 75 5.2.3.2 Increasing shift towards outpatient care 76 5.2.3.3 Improving regulatory support and reimbursements 76 5.2.3.4 Advancements in digital health 77 5.2.4 CHALLENGES 77 5.2.4.1 Healthcare gap in emerging economies 77 5.2.4.2 Privacy and security concerns 78 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 80 5.4 INDUSTRY TRENDS 80 5.4.1 EMERGENCE OF VALUE-BASED STRATEGY FOR CONTINUOUS CARE 80 5.4.2 HOME: NEW HEALTHCARE HUB 81 5.4.3 TECHNOLOGICALLY ENABLED PRIMARY CARE SERVICES 81 5.4.4 RISING AWARENESS OF DIGITAL THERAPEUTICS TO TREAT HUMAN DISEASES 81 5.4.5 SURGE IN MHEALTH APPS 81 5.5 ECOSYSTEM ANALYSIS 82 5.6 SUPPLY CHAIN ANALYSIS 84 5.7 TECHNOLOGY ANALYSIS 85 5.7.1 KEY TECHNOLOGIES 85 5.7.1.1 mHealth apps 85 5.7.1.2 Wearable sensors & devices 86 5.7.1.3 Remote patient monitoring 86 5.7.1.4 Digital therapeutics 87 5.7.1.5 Telehealth/virtual care platforms 87 5.7.1.6 AI-powered tools 88 5.7.2 COMPLEMENTARY TECHNOLOGIES 88 5.7.2.1 Cloud computing & edge processing 88 5.7.2.2 Data analytics & visualization 88 5.7.2.3 Bluetooth & IoT connectivity 89 5.7.2.4 EHR integration 89 5.7.3 ADJACENT TECHNOLOGIES 89 5.7.3.1 Digital twins 89 5.7.3.2 AR/VR & extended reality (XR) 90 5.7.3.3 Voice assistants/smart speakers 90 5.8 TARIFF AND REGULATORY ANALYSIS 91 5.8.1 TARIFF DATA FOR HS CODE 9018 91 5.8.2 TARIFF DATA FOR HS CODE 9021 92 5.8.3 TARIFF DATA FOR HS CODE 8517 93 5.8.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 5.8.5 REGULATORY FRAMEWORK 102 5.9 PRICING ANALYSIS 104 5.9.1 INDICATIVE PRICE, BY OFFERING 105 5.9.2 INDICATIVE PRICE, BY REGION 106 5.10 PORTER’S FIVE FORCES ANALYSIS 106 5.10.1 INTENSITY OF COMPETITIVE RIVALRY 107 5.10.2 BARGAINING POWER OF BUYERS 107 5.10.3 THREAT OF SUBSTITUTES 107 5.10.4 THREAT OF NEW ENTRANTS 108 5.10.5 BARGAINING POWER OF SUPPLIERS 108 5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 108 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 108 5.11.2 BUYING CRITERIA 109 5.12 PATENT ANALYSIS 110 5.12.1 PATENT PUBLICATION TRENDS FOR DIGITAL HEALTH MARKET 110 5.12.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIGITAL HEALTH 111 5.12.3 MAJOR PATENTS IN DIGITAL HEALTH MARKET 112 5.13 UNMET NEEDS AND END-USER EXPECTATIONS 113 5.13.1 UNMET NEEDS IN DIGITAL HEALTH MARKET 113 5.13.2 END-USER EXPECTATIONS 113 5.14 KEY CONFERENCES AND EVENTS 114 5.15 CASE STUDY ANALYSIS 115 5.15.1 CASE STUDY 1: CLÍNICAS DEL AZÚCAR (CDA) 115 5.15.2 CASE STUDY 2: NOVA HOSPITAL & ENOVACOM 116 5.15.3 CASE STUDY 3: APPLE & NHS TEAMS 116 5.16 DIGITAL HEALTH MARKET: INVESTMENT LANDSCAPE AND FUNDING SCENARIO 117 5.17 TRADE ANALYSIS 117 5.17.1 TRADE ANALYSIS FOR DIGITAL HEALTH DEVICES (HSN CODE 8518) 118 5.17.2 TRADE ANALYSIS FOR DIGITAL HEALTH DEVICES (HSN CODE 9021) 119 5.17.3 TRADE ANALYSIS FOR DIGITAL HEALTH DEVICES (HSN CODE 9022) 120 5.17.4 TRADE ANALYSIS FOR DIGITAL HEALTH DEVICES (HSN CODE 9018) 121 5.18 DIGITAL HEALTH MARKET BUSINESS MODELS 122 5.18.1 SUBSCRIPTION-BASED MODELS 122 5.18.2 SOFTWARE AS A SERVICE (SAAS)/PLATFORM AS A SERVICE (PAAS) 122 5.18.3 FREEMIUM MODELS WITH TIERED ACCESS 122 5.18.4 OUTCOMES-BASED AND VALUE-BASED MODELS 122 5.19 IMPACT OF AI/GEN AI IN DIGITAL HEALTH MARKET 123 5.19.1 KEY USE CASES 124 5.19.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 125 5.19.2.1 Artificial intelligence in public health 125 5.19.2.2 Artificial intelligence in digital health—issues and dimensions of ethical concerns 126 5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 126 5.19.3.1 Telehealth and telemedicine 127 5.19.3.2 Wearable devices 127 5.19.3.3 Remote patient monitoring (RPM) 127 5.19.3.4 Mobile health (mHealth) 127 5.19.4 USER READINESS & IMPACT ASSESSMENT 127 5.19.4.1 User readiness 127 5.19.4.1.1 User A: Healthcare providers 127 5.19.4.1.2 User B: Healthcare payers 128 5.19.4.1.3 User C: Patients & consumers 128 5.19.4.1.4 User D: Pharmaceutical, biotech, and MedTech companies (including CROs) 128 5.19.4.1.5 User E: Other end users (academic institutes, research centers, government bodies) 128 5.19.4.2 Impact assessment 128 5.19.4.2.1 User A: Healthcare providers 128 5.19.4.2.1.1 Implementation 128 5.19.4.2.1.2 Impact 128 5.19.4.2.2 User B: Healthcare payers 129 5.19.4.2.2.1 Implementation 129 5.19.4.2.2.2 Impact 129 5.19.4.2.3 User C: Patients & consumers 129 5.19.4.2.3.1 Implementation 129 5.19.4.2.3.2 Impact 129 5.19.4.2.4 User D: Pharmaceutical, biotech, and MedTech companies (including CROs) 130 5.19.4.2.4.1 Implementation 130 5.19.4.2.4.2 Impact 130 5.19.4.2.5 User E: Other end users (academic institutes, research centers, government bodies) 130 5.19.4.2.5.1 Implementation 130 5.19.4.2.5.2 Impact 130 5.20 IMPACT OF 2025 US TARIFFS—DIGITAL HEALTH MARKET 131 5.20.1 INTRODUCTION 131 5.20.2 KEY TARIFF RATES 132 5.20.3 PRICE IMPACT ANALYSIS 132 5.20.4 IMPACT ON COUNTRIES/REGIONS 133 5.20.4.1 US 133 5.20.5 EUROPE 134 5.20.6 ASIA PACIFIC 134 5.20.7 IMPACT ON END-USE INDUSTRIES 135 5.20.7.1 Healthcare providers 135 5.20.7.2 Healthcare payers 135 5.20.7.3 Patients and consumers 135 5.20.7.4 Pharmaceutical, biotechnology, and MedTech companies 135 5.20.7.5 Other end users 136 5.21 REIMBURSEMENT ANALYSIS 136 5.22 RISK FACTORS AND MARKET ENTRY BARRIERS 139 5.23 FUTURE OUTLOOK AND DISRUPTION SCENARIOS 140 6 DIGITAL HEALTH MARKET, BY OFFERING 141 6.1 INTRODUCTION 142 6.2 HARDWARE 142 6.2.1 SMART HARDWARE SOLUTIONS VITAL IN POWERING DIGITAL HEALTH 142 6.2.2 WEARABLES 143 6.2.2.1 Wearables to empower patients with real-time health monitoring 143 6.2.3 CONSUMER-GRADED WEARABLE HEALTHCARE DEVICES 144 6.2.3.1 Wearable healthcare devices to empower consumers to be proactive about their well-being 144 6.2.4 CLINICAL-GRADE WEARABLE HEALTHCARE DEVICES 145 6.2.4.1 Clinical-grade devices to allow remote care with continuous monitoring 145 6.2.5 IMPLANTABLE DEVICES 146 6.2.5.1 Real-time data transmission to healthcare providers for proactive intervention and personalized care 146 6.2.6 HANDHELD & PORTABLE DEVICES 147 6.2.6.1 Compact design and integration with mobile health applications to make them highly effective for use in remote care 147 6.2.7 STATIONARY DEVICES 148 6.2.7.1 Stationary devices to be upgraded with IoT integration, AI-driven analytics, and cloud-enabled interoperability 148 6.3 SOLUTIONS/APPLICATIONS 148 6.3.1 TELEHEALTHCARE/TELEMEDICINE 150 6.3.1.1 Demand to advance connected care via virtual health platforms 150 6.3.2 REMOTE PATIENT MONITORING 150 6.3.2.1 Expected to be more seamlessly integrated with telemedicine platforms, expanding their capabilities 150 6.3.3 VIRTUAL CARE & VIDEO CONSULTATION 151 6.3.3.1 Offering enhanced efficiency, accessibility, and accuracy in remote healthcare, assisting in triaging patients and automating documentation 151 6.3.4 VIRTUAL SITTING & NURSING PLATFORMS 152 6.3.4.1 Offering remote patient monitoring with bidirectional communication 152 6.4 MHEALTH APPS 153 6.4.1 TRANSFORMING CARE DELIVERY WITH MOBILE HEALTH SOLUTIONS 153 6.5 DIGITAL THERAPEUTICS 154 6.5.1 EMPOWERING HEALTH BY COMBINING REAL-TIME DATA COLLECTION, PATIENT ENGAGEMENT TOOLS, AND INTEGRATION WITH HEALTHCARE PROVIDERS’ SYSTEMS 154 6.6 DIGITAL PHARMACY & MEDICATION ACCESS 155 6.6.1 ENHANCING MEDICATION ACCESS BY REACHING RURAL OR UNDERSERVED POPULATIONS, REDUCING TRAVEL AND WAIT TIMES, AND IMPROVING CONTINUITY OF CARE 155 6.7 DIGITAL DIAGNOSTICS & AT-HOME TESTING 156 6.7.1 MOSTLY USED IN GLUCOSE MONITORING AND OTHER INFECTIOUS DISEASE TESTS, CHOLESTEROL AND LIPID PANELS, GENETIC TESTING, AND HORMONE OR FERTILITY ASSESSMENTS 156 6.8 PATIENT PORTALS 157 6.8.1 PERSONALIZED HEALTH CONTENT, APPOINTMENT REMINDERS, AND SECURE MESSAGING AIM TO IMPROVE PATIENT ENGAGEMENT AND CARE COORDINATION 157 6.9 OTHER DIGITAL HEALTH SOLUTIONS/APPLICATIONS 158 7 DIGITAL HEALTH MARKET, BY DISEASE 160 7.1 INTRODUCTION 161 7.2 DIABETES 162 7.2.1 INTEGRATING AI IN DIGITAL HEALTH TO CATER TO DIABETIC PATIENTS 162 7.3 CARDIOLOGY 163 7.3.1 OFFERING EARLIER DETECTION, CONTINUOUS MONITORING, AND PERSONALIZED MANAGEMENT OF CARDIOVASCULAR CONDITIONS 163 7.4 MENTAL HEALTH & BEHAVIORAL HEALTH 164 7.4.1 IMPROVING ACCESSIBILITY TO MENTAL HEALTH SERVICES, ESPECIALLY IN UNDERSERVED REGIONS 164 7.5 RESPIRATORY DISORDERS 165 7.5.1 ENABLING REAL-TIME MONITORING OF LUNG FUNCTION, MEDICATION ADHERENCE, AND OXYGEN LEVELS 165 7.6 LIFESTYLE & WELLNESS IMPROVEMENT 166 7.6.1 EXPANDING ACCESS AND PERSONALIZING CARE IN MENTAL & BEHAVIORAL HEALTH THROUGH DIGITAL HEALTH 166   7.7 NEUROLOGY 166 7.7.1 ADVANCING NEUROLOGICAL CARE WITH DIGITAL HEALTH INNOVATIONS 166 7.8 MUSCULOSKELETAL DISORDERS/PAIN MANAGEMENT 167 7.8.1 ACCELERATING INNOVATION IN HANDHELD & PORTABLE DEVICES TO BOOST MARKET GROWTH 167 7.9 ONCOLOGY 168 7.9.1 ADOPTION OF AI IN REMOTE PATIENT MONITORING (RPM) TO LEAD TO ITS EMERGING AS PROMISING SOLUTION TO SUPPORT PERSONALIZED CARE 168 7.10 WOMEN’S HEALTH & REPRODUCTIVE HEALTH 169 7.10.1 ENHANCING PREVENTIVE CARE, EMPOWERING WOMEN WITH SELF-MANAGEMENT TOOLS, AND STRENGTHENING OUTCOMES IN REPRODUCTIVE AND MATERNAL HEALTH 169 7.11 OTHER DISEASES 170 8 DIGITAL HEALTH MARKET, BY USE CASE 171 8.1 INTRODUCTION 172 8.2 PREVENTIVE CARE & WELLNESS 172 8.2.1 DRIVING PROACTIVE HEALTH MANAGEMENT THROUGH DIGITAL INNOVATION 172 8.3 DIAGNOSIS 173 8.3.1 ADVANCING DIAGNOSIS THROUGH AI-POWERED SYMPTOM CHECKING AND EARLY DETECTION 173 8.4 TREATMENT 174 8.4.1 FEEDING REAL-TIME DATA TO HEALTHCARE PROVIDERS, ALLOWING TREATMENT ADJUSTMENTS AND PROACTIVE INTERVENTIONS 174 8.5 PATIENT MONITORING 175 8.5.1 SHIFT TOWARD PERSONALIZED, SCALABLE, AND PREVENTIVE CARE 175 8.6 REHABILITATION & RECOVERY 176 8.6.1 PARTICULARLY IMPACTFUL IN POST-SURGICAL CARE, NEUROLOGICAL REHABILITATION, STROKE RECOVERY, AND MUSCULOSKELETAL THERAPY 176 8.7 OTHER USE CASES 177 9 DIGITAL HEALTH MARKET, BY END USER 179 9.1 INTRODUCTION 180 9.2 HEALTHCARE PROVIDERS 180 9.2.1 HOSPITALS 182 9.2.1.1 Rise in demand for high-quality care and government support to encourage digital health adoption in hospitals 182 9.2.2 CLINICS & OTHER OUTPATIENT SETTINGS 182 9.2.2.1 Increase in demand for cost-effective care and postoperative monitoring to drive digital health adoption in outpatient settings 182 9.2.3 OTHER HEALTHCARE PROVIDERS 183 9.3 HEALTHCARE PAYERS 184 9.3.1 PUBLIC PAYERS 185 9.3.1.1 Driving population health and value-based care through digital innovation 185 9.3.2 PRIVATE PAYERS 186 9.3.2.1 Personalized benefit designs, value-based provider contracting, and delivering consumer-centric experiences 186 9.4 PATIENTS & CONSUMERS 187 9.4.1 AI AND WEARABLE DEVICES TO DRIVE GROWTH IN DIGITAL HEALTH FOR PERSONALIZED CARE AND ACCESSIBILITY 187 9.5 PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDTECH COMPANIES 188 9.5.1 PHARMACEUTICAL AND BIOTECH ADOPTION OF DIGITAL HEALTH TO ENHANCE DRUG DEVELOPMENT, PATIENT ENGAGEMENT, AND ADHERENCE 188 9.6 OTHER END USERS 189 10 DIGITAL HEALTH MARKET, BY REGION 190 10.1 INTRODUCTION 191 10.2 NORTH AMERICA 192 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 192 10.2.2 US 198 10.2.2.1 Integration of AI, data interoperability, and virtual-first care models to drive market 198 10.2.3 CANADA 204 10.2.3.1 Advancing health equity and access through digital infrastructure 204 10.3 EUROPE 209 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 209 10.3.2 GERMANY 214 10.3.2.1 Innovation-focused policy framework and digital infrastructure expansion to support growth 214 10.3.3 UK 219 10.3.3.1 Increase in prevalence of chronic and lifestyle-related diseases and high penetration of wearables to drive market 219 10.3.4 FRANCE 224 10.3.4.1 Government support for e-Health to propel market 224 10.3.5 ITALY 229 10.3.5.1 Digital transformation and integrated care to support market growth 229 10.3.6 SPAIN 234 10.3.6.1 Health system modernization and data-driven care to enable digital health growth in Spain 234 10.3.7 REST OF EUROPE 239 10.4 ASIA PACIFIC 244 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 245 10.4.2 CHINA 251 10.4.2.1 High burden of chronic diseases to fuel market growth 251 10.4.3 JAPAN 256 10.4.3.1 Large geriatric population and strong push toward modernization to propel market 256   10.4.4 INDIA 261 10.4.4.1 Growing adoption of telemedicine and mounting pressure to reduce healthcare expenditure to drive market 261 10.4.5 AUSTRALIA 266 10.4.5.1 Telehealth and digital integration to drive growth in Australia’s digital health market 266 10.4.6 SOUTH KOREA 271 10.4.6.1 AI, data ecosystems, and cross-sector synergy to power South Korea’s digital health growth 271 10.4.7 REST OF ASIA PACIFIC 276 10.5 LATIN AMERICA 281 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 281 10.5.2 BRAZIL 286 10.5.2.1 Government digitalization push and interoperability frameworks to catalyze market expansion 286 10.5.3 MEXICO 291 10.5.3.1 Government reforms, infrastructural expansion, and chronic disease burden to drive market 291 10.5.4 REST OF LATIN AMERICA 296 10.6 MIDDLE EAST & AFRICA 301 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 302 10.6.2 GCC 307 10.6.2.1 AI leadership, virtual infrastructure, and policy alignment to power digital health growth in GCC 307 10.6.2.2 Saudi Arabia 312 10.6.2.2.1 Rapid digital health transformation to propel market in Saudi Arabia 312 10.6.2.3 UAE 317 10.6.2.3.1 UAE emerges as regional pioneer in digital healthcare innovation 317 10.6.2.4 Rest of GCC 322 10.6.3 SOUTH AFRICA 327 10.6.3.1 Infrastructure expansion, youthful demographics, and innovation ecosystems to accelerate digital health growth 327 10.6.4 REST OF MIDDLE EAST & AFRICA 332 11 COMPETITIVE LANDSCAPE 337 11.1 INTRODUCTION 337 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 337 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL HEALTH MARKET 337 11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 339 11.4 MARKET SHARE ANALYSIS, 2024 340 11.5 BRAND/SOFTWARE COMPARISON 343 11.6 COMPANY VALUATION & FINANCIAL METRICS 344 11.6.1 FINANCIAL METRICS 344 11.6.2 COMPANY VALUATION 345 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 345 11.7.1 STARS 345 11.7.2 EMERGING LEADERS 345 11.7.3 PERVASIVE PLAYERS 346 11.7.4 PARTICIPANTS 346 11.7.5 COMPANY FOOTPRINT 347 11.7.6 REGION FOOTPRINT 348 11.7.7 OFFERING FOOTPRINT 349 11.7.8 DISEASE FOOTPRINT 350 11.7.9 USE CASE FOOTPRINT 351 11.7.10 END USER FOOTPRINT 352 11.8 STARTUP/SME EVALUATION MATRIX, 2024 353 11.8.1 PROGRESSIVE COMPANIES 353 11.8.2 DYNAMIC COMPANIES 353 11.8.3 RESPONSIVE COMPANIES 353 11.8.4 STARTING BLOCKS 353 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 355 11.8.5.1 Detailed list of key startups/SMEs 355 11.8.5.2 Competitive benchmarking of startups/SMEs 355 11.9 COMPETITIVE SCENARIO AND TRENDS 356 11.9.1 PRODUCT LAUNCHES & APPROVALS 356 11.9.2 DEALS 357 11.9.3 OTHER DEVELOPMENTS 358 12 COMPANY PROFILES 359 12.1 KEY PLAYERS 359 12.1.1 MEDTRONIC 359 12.1.1.1 Business overview 359 12.1.1.2 Products offered 360 12.1.1.3 Recent developments 362 12.1.1.3.1 Product launches & approvals 362 12.1.1.3.2 Deals 363 12.1.1.3.3 Other developments 364 12.1.1.4 MnM view 364 12.1.1.4.1 Key strengths 364 12.1.1.4.2 Strategic choices 364 12.1.1.4.3 Weaknesses and competitive threats 365 12.1.2 ABBOTT 366 12.1.2.1 Business overview 366 12.1.2.2 Products offered 367 12.1.2.3 Recent developments 368 12.1.2.3.1 Product launches & approvals 368 12.1.2.3.2 Deals 369 12.1.2.4 MnM view 369 12.1.2.4.1 Key strengths 369 12.1.2.4.2 Strategic choices 370 12.1.2.4.3 Weaknesses and competitive threats 370 12.1.3 DEXCOM, INC. 371 12.1.3.1 Business overview 371 12.1.3.2 Products offered 372 12.1.3.3 Recent developments 372 12.1.3.3.1 Product launches & approvals 372 12.1.3.3.2 Deals 373 12.1.3.4 MnM view 374 12.1.3.4.1 Key strengths 374 12.1.3.4.2 Strategic choices 374 12.1.3.4.3 Weaknesses and competitive threats 374 12.1.4 KONINKLIJKE PHILIPS N.V. 375 12.1.4.1 Business overview 375 12.1.4.2 Products offered 376 12.1.4.3 Recent developments 378 12.1.4.3.1 Product launches & approvals 378 12.1.4.3.2 Deals 378 12.1.4.3.3 Expansions 379 12.1.4.4 MnM view 379 12.1.4.4.1 Key strengths 379 12.1.4.4.2 Strategic choices 379 12.1.4.4.3 Weaknesses and competitive threats 379 12.1.5 FITBIT, INC. (GOOGLE) 380 12.1.5.1 Business overview 380 12.1.5.2 Products offered 381 12.1.5.3 Recent developments 382 12.1.5.3.1 Product launches & approvals 382 12.1.5.3.2 Deals 382 12.1.5.4 MnM view 383 12.1.5.4.1 Key strengths 383 12.1.5.4.2 Strategic choices 383 12.1.5.4.3 Weaknesses and competitive threats 383 12.1.6 OMRON HEALTHCARE, INC. 384 12.1.6.1 Business overview 384 12.1.6.2 Products offered 385 12.1.6.3 Recent developments 387 12.1.6.3.1 Product launches & approvals 387 12.1.6.3.2 Deals 387 12.1.7 APPLE, INC. 389 12.1.7.1 Business overview 389 12.1.7.2 Products offered 390 12.1.7.3 Recent developments 391 12.1.7.3.1 Product launches & approvals 391 12.1.7.3.2 Deals 392 12.1.8 BOSTON SCIENTIFIC CORPORATION 393 12.1.8.1 Business overview 393 12.1.8.2 Products offered 394 12.1.8.3 Recent developments 395 12.1.8.3.1 Product launches & approvals 395 12.1.8.3.2 Deals 396 12.1.9 MASIMO 397 12.1.9.1 Business overview 397 12.1.9.2 Products offered 398 12.1.9.3 Recent developments 399 12.1.9.3.1 Product launches & approvals 399 12.1.9.3.2 Deals 400 12.1.10 TELADOC HEALTH, INC. 401 12.1.10.1 Business overview 401 12.1.10.2 Products offered 402 12.1.10.3 Recent developments 403 12.1.10.3.1 Product launches & approvals 403 12.1.10.3.2 Deals 404 12.1.11 AMERICAN WELL 406 12.1.11.1 Business overview 406 12.1.11.2 Products offered 407 12.1.11.3 Recent developments 408 12.1.11.3.1 Product launches & approvals 408 12.1.11.3.2 Deals 408 12.1.11.3.3 Other developments 409 12.1.12 HIMS & HERS HEALTH, INC. 410 12.1.12.1 Business overview 410 12.1.12.2 Products offered 411 12.1.12.3 Recent developments 412 12.1.12.3.1 Product launches & approvals 412 12.1.12.3.2 Deals 413   12.1.13 HEADSPACE 414 12.1.13.1 Business overview 414 12.1.13.2 Products offered 414 12.1.13.3 Recent developments 415 12.1.13.3.1 Product launches & approvals 415 12.1.13.3.2 Deals 416 12.1.14 NOOM, INC. 417 12.1.14.1 Business overview 417 12.1.14.2 Products offered 417 12.1.14.3 Recent developments 418 12.1.14.3.1 Product launches & approvals 418 12.1.14.3.2 Deals 418 12.1.15 CEREBRAL INC. 420 12.1.15.1 Business overview 420 12.1.15.2 Products offered 420 12.1.15.3 Recent developments 421 12.1.15.3.1 Product launches & approvals 421 12.1.15.3.2 Deals 421 12.1.16 EPIC SYSTEMS CORPORATION 423 12.1.16.1 Business overview 423 12.1.16.2 Products offered 423 12.1.16.3 Recent developments 424 12.1.16.3.1 Product launches & approvals 424 12.1.16.3.2 Deals 424 12.1.17 OMADA HEALTH INC. 425 12.1.17.1 Business overview 425 12.1.17.2 Products offered 426 12.1.17.3 Recent developments 427 12.1.17.3.1 Product launches & approvals 427 12.1.17.3.2 Deals 428 12.1.18 ORACLE 429 12.1.18.1 Business overview 429 12.1.18.2 Products offered 430 12.1.18.3 Recent developments 431 12.1.18.3.1 Product launches & approvals 431 12.1.18.3.2 Deals 431 12.1.19 CLICK THERAPEUTICS, INC. 432 12.1.19.1 Business overview 432 12.1.19.2 Products offered 432 12.1.19.3 Recent developments 433 12.1.19.3.1 Product launches & approvals 433 12.1.19.3.2 Deals 434 12.1.20 WELLDOC, INC. 435 12.1.20.1 Business overview 435 12.1.20.2 Products offered 435 12.1.20.3 Recent developments 436 12.1.20.3.1 Product launches & approvals 436 12.1.20.3.2 Deals 436 12.1.21 EVERLYWELL 437 12.1.21.1 Business overview 437 12.1.21.2 Products offered 437 12.1.21.3 Recent developments 438 12.1.21.3.1 Product launches & approvals 438 12.1.21.3.2 Deals 439 12.2 OTHER PLAYERS 440 12.2.1 TRUDOC HEALTHCARE LLC 440 12.2.2 CARESIMPLE INC. 441 12.2.3 VIVALNK, INC. 441 12.2.4 BIOBEAT 442 12.2.5 VIRTUAL THERAPEUTICS CORP. 442 13 APPENDIX 443 13.1 DISCUSSION GUIDE 443 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 448 13.3 CUSTOMIZATION OPTIONS 450 13.4 RELATED REPORTS 450 13.5 AUTHOR DETAILS 451

TABLE 1 FACTOR ANALYSIS 55 TABLE 2 LARGEST HEALTHCARE DATA BREACHES (2021–2025) 78 TABLE 3 AVERAGE TARIFFS UNDER HS CODE 9018 91 TABLE 4 AVERAGE TARIFFS UNDER HS CODE 9021 92 TABLE 5 AVERAGE TARIFFS UNDER HS CODE 8517 93 TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98 TABLE 9 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 TABLE 10 DIGITAL HEALTH MARKET: REGULATORY STANDARDS 101 TABLE 11 REGULATORY REQUIREMENTS IN NORTH AMERICA 102 TABLE 12 REGULATORY REQUIREMENTS IN EUROPE 103 TABLE 13 REGULATORY REQUIREMENTS IN ASIA PACIFIC 103 TABLE 14 REGULATORY REQUIREMENTS IN LATIN AMERICA 104 TABLE 15 REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA 104 TABLE 16 INDICATIVE PRICE OF DIGITAL HEALTH SOLUTIONS, BY OFFERING, 2024 105 TABLE 17 INDICATIVE PRICE OF DIGITAL HEALTH SOLUTIONS, BY REGION, 2024 106 TABLE 18 DIGITAL HEALTH MARKET: PORTER’S FIVE FORCES ANALYSIS 107 TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 109 TABLE 20 KEY BUYING CRITERIA FOR DIGITAL HEALTH MARKET OFFERINGS 109 TABLE 21 UNMET NEEDS IN DIGITAL HEALTH MARKET 113 TABLE 22 END-USER EXPECTATIONS IN DIGITAL HEALTH MARKET 113 TABLE 23 DIGITAL HEALTH MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 114 TABLE 24 US ADJUSTED RECIPROCAL TARIFF RATES 132 TABLE 25 DIGITAL HEALTH MARKET: CPT CODES AND REIMBURSEMENT ANALYSIS 137 TABLE 26 DIGITAL HEALTH MARKET: RISK FACTORS AND MARKET ENTRY BARRIERS 139 TABLE 27 DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 142 TABLE 28 DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 142 TABLE 29 DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 143 TABLE 30 DIGITAL HEALTH WEARABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 31 CONSUMER-GRADED WEARABLE HEALTHCARE DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 32 CLINICAL-GRADE WEARABLE HEALTHCARE DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 145 TABLE 33 IMPLANTABLE DIGITAL HEALTH DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 34 HANDHELD & PORTABLE DIGITAL HEALTH DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 35 STATIONARY DIGITAL HEALTH DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 36 DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 37 DIGITAL HEALTH SERVICES SOLUTIONS/APPLICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 38 TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 39 COMPANIES OFFERING DIGITAL HEALTH SOLUTIONS FOR REMOTE PATIENT MONITORING 151 TABLE 40 REMOTE PATIENT MONITORING SOLUTIONS/APPLICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 41 COMPANIES OFFERING DIGITAL HEALTH SOLUTIONS FOR VIRTUAL CARE 152 TABLE 42 VIRTUAL CARE & VIDEO CONSULTATION SOLUTIONS/APPLICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 152 TABLE 43 COMPANIES OFFERING VIRTUAL SITTING & NURSING PLATFORMS 153 TABLE 44 VIRTUAL SITTING & NURSING PLATFORMS MARKET, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 45 MHEALTH APPS MARKET, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 46 DIGITAL THERAPEUTICS MARKET, BY REGION, 2023–2030 (USD MILLION) 155 TABLE 47 DIGITAL PHARMACY & MEDICATION ACCESS SOLUTIONS/APPLICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 48 DIGITAL DIAGNOSTICS & AT-HOME TESTING SOLUTIONS/APPLICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 49 PATIENT PORTAL SOLUTIONS/APPLICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 158 TABLE 50 OTHER DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 159 TABLE 51 DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 161 TABLE 52 COMPANIES OFFERING DIGITAL HEALTH FOR DIABETES SOLUTIONS 162 TABLE 53 DIGITAL HEALTH MARKET FOR DIABETES, BY REGION, 2023–2030 (USD MILLION) 162 TABLE 54 DIGITAL HEALTH MARKET FOR CARDIOLOGY, BY REGION, 2023–2030 (USD MILLION) 163 TABLE 55 DIGITAL HEALTH MARKET FOR MENTAL HEALTH & BEHAVIORAL HEALTH, BY REGION, 2023–2030 (USD MILLION) 164 TABLE 56 COMPANIES OFFERING DIGITAL HEALTH SOLUTIONS FOR RESPIRATORY DISORDERS 165 TABLE 57 DIGITAL HEALTH MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2023–2030 (USD MILLION) 165 TABLE 58 DIGITAL HEALTH MARKET FOR LIFESTYLE & WELLNESS IMPROVEMENT, BY REGION, 2023–2030 (USD MILLION) 166 TABLE 59 DIGITAL HEALTH MARKET FOR NEUROLOGY, BY REGION, 2023–2030 (USD MILLION) 167 TABLE 60 DIGITAL HEALTH MARKET FOR MUSCULOSKELETAL DISORDERS/PAIN MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 168 TABLE 61 DIGITAL HEALTH MARKET FOR ONCOLOGY, BY REGION, 2023–2030 (USD MILLION) 169 TABLE 62 DIGITAL HEALTH MARKET FOR WOMEN’S HEALTH & REPRODUCTIVE HEALTH, BY REGION, 2023–2030 (USD MILLION) 170 TABLE 63 DIGITAL HEALTH MARKET FOR OTHER DISEASES, BY REGION, 2023–2030 (USD MILLION) 170 TABLE 64 DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 172 TABLE 65 DIGITAL HEALTH MARKET FOR PREVENTIVE CARE & WELLNESS, BY REGION, 2023–2030 (USD MILLION) 173 TABLE 66 DIGITAL HEALTH MARKET FOR DIAGNOSIS, BY REGION, 2023–2030 (USD MILLION) 174 TABLE 67 DIGITAL HEALTH MARKET FOR TREATMENT, BY REGION, 2023–2030 (USD MILLION) 175 TABLE 68 DIGITAL HEALTH MARKET FOR PATIENT MONITORING, BY REGION, 2023–2030 (USD MILLION) 176 TABLE 69 DIGITAL HEALTH MARKET FOR REHABILITATION & RECOVERY, BY REGION, 2023–2030 (USD MILLION) 177 TABLE 70 DIGITAL HEALTH MARKET FOR OTHER USE CASES, BY REGION, 2023–2030 (USD MILLION) 178 TABLE 71 DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 180 TABLE 72 DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 73 DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 181 TABLE 74 DIGITAL HEALTH MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 182 TABLE 75 DIGITAL HEALTH MARKET FOR CLINICS & OTHER OUTPATIENT SETTINGS, BY REGION, 2023–2030 (USD MILLION) 183 TABLE 76 DIGITAL HEALTH MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 184 TABLE 77 DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023–2030 (USD MILLION) 185 TABLE 78 DIGITAL HEALTH MARKET FOR PUBLIC PAYERS, BY REGION, 2023–2030 (USD MILLION) 186 TABLE 79 DIGITAL HEALTH MARKET FOR PRIVATE PAYERS, BY REGION, 2023–2030 (USD MILLION) 187 TABLE 80 DIGITAL HEALTH MARKET FOR PATIENTS & CONSUMERS, BY REGION, 2023–2030 (USD MILLION) 188 TABLE 81 DIGITAL HEALTH MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDTECH COMPANIES, BY REGION, 2023–2030 (USD MILLION) 189 TABLE 82 DIGITAL HEALTH MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 189 TABLE 83 DIGITAL HEALTH MARKET, BY REGION, 2023–2030 (USD MILLION) 191 TABLE 84 NORTH AMERICA: DIGITAL HEALTH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 85 NORTH AMERICA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 194 TABLE 86 NORTH AMERICA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 87 NORTH AMERICA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 88 NORTH AMERICA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 89 NORTH AMERICA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 90 NORTH AMERICA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 196 TABLE 91 NORTH AMERICA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 196 TABLE 92 NORTH AMERICA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 197 TABLE 93 NORTH AMERICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 94 NORTH AMERICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 95 US: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 198 TABLE 96 US: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 97 US: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 98 US: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 99 US: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 100 US: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 202 TABLE 101 US: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 202 TABLE 102 US: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 203 TABLE 103 US: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 104 US: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 105 CANADA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 205 TABLE 106 CANADA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 107 CANADA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 108 CANADA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 109 CANADA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 110 CANADA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 207 TABLE 111 CANADA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 207 TABLE 112 CANADA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 208 TABLE 113 CANADA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 114 CANADA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 115 EUROPE: DIGITAL HEALTH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 210 TABLE 116 EUROPE: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 210 TABLE 117 EUROPE: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 118 EUROPE: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 119 EUROPE: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 120 EUROPE: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 121 EUROPE: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 212 TABLE 122 EUROPE: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 213 TABLE 123 EUROPE: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 213 TABLE 124 EUROPE: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 125 EUROPE: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 126 GERMANY: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 215 TABLE 127 GERMANY: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 128 GERMANY: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 129 GERMANY: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 130 GERMANY: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 131 GERMANY: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 217 TABLE 132 GERMANY: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 218 TABLE 133 GERMANY: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 218 TABLE 134 GERMANY: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 135 GERMANY: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 136 UK: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 220 TABLE 137 UK: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 138 UK: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 139 UK: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 140 UK: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 141 UK: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 222 TABLE 142 UK: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 222 TABLE 143 UK: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 223 TABLE 144 UK: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 145 UK: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 146 FRANCE: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 224 TABLE 147 FRANCE: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 148 FRANCE: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 149 FRANCE: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 150 FRANCE: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 151 FRANCE: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 227 TABLE 152 FRANCE: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 227 TABLE 153 FRANCE: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 228 TABLE 154 FRANCE: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 155 FRANCE: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 156 ITALY: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 230 TABLE 157 ITALY: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 158 ITALY: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 159 ITALY: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 160 ITALY: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 161 ITALY: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 232 TABLE 162 ITALY: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 232 TABLE 163 ITALY: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 233 TABLE 164 ITALY: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 165 ITALY: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 166 SPAIN: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 235 TABLE 167 SPAIN: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 168 SPAIN: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 169 SPAIN: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 170 SPAIN: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 171 SPAIN: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 237 TABLE 172 SPAIN: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 237 TABLE 173 SPAIN: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 238 TABLE 174 SPAIN: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 175 SPAIN: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 176 REST OF EUROPE: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 239 TABLE 177 REST OF EUROPE: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 178 REST OF EUROPE: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 179 REST OF EUROPE: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 180 REST OF EUROPE: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 181 REST OF EUROPE: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 242 TABLE 182 REST OF EUROPE: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 242 TABLE 183 REST OF EUROPE: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 243 TABLE 184 REST OF EUROPE: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 185 REST OF EUROPE: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 186 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 187 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 247 TABLE 188 ASIA PACIFIC: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 189 ASIA PACIFIC: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 190 ASIA PACIFIC: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 191 ASIA PACIFIC: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 192 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 249 TABLE 193 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 249 TABLE 194 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 250 TABLE 195 ASIA PACIFIC: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 196 ASIA PACIFIC: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 197 CHINA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 251 TABLE 198 CHINA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 199 CHINA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 200 CHINA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 201 CHINA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 202 CHINA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 254 TABLE 203 CHINA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 254 TABLE 204 CHINA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 255 TABLE 205 CHINA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 206 CHINA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 207 JAPAN: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 257 TABLE 208 JAPAN: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 209 JAPAN: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 210 JAPAN: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 211 JAPAN: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 212 JAPAN: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 259 TABLE 213 JAPAN: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 259 TABLE 214 JAPAN: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 260 TABLE 215 JAPAN: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 216 JAPAN: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 217 INDIA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 262 TABLE 218 INDIA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 219 INDIA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 220 INDIA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 221 INDIA: TELEHEALTHCARE/ TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 222 INDIA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 264 TABLE 223 INDIA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 264 TABLE 224 INDIA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 265 TABLE 225 INDIA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 226 INDIA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 227 AUSTRALIA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 266 TABLE 228 AUSTRALIA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 229 AUSTRALIA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 230 AUSTRALIA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 231 AUSTRALIA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 232 AUSTRALIA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 269 TABLE 233 AUSTRALIA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 269 TABLE 234 AUSTRALIA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 270 TABLE 235 AUSTRALIA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 236 AUSTRALIA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 237 SOUTH KOREA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 271 TABLE 238 SOUTH KOREA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 239 SOUTH KOREA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 240 SOUTH KOREA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 241 SOUTH KOREA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 242 SOUTH KOREA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 274 TABLE 243 SOUTH KOREA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 274 TABLE 244 SOUTH KOREA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 275 TABLE 245 SOUTH KOREA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 246 SOUTH KOREA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 247 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 276 TABLE 248 REST OF ASIA PACIFIC: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 249 REST OF ASIA PACIFIC: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 250 REST OF ASIA PACIFIC: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 251 REST OF ASIA PACIFIC: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 252 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 279 TABLE 253 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 279 TABLE 254 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 280 TABLE 255 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 256 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 257 LATIN AMERICA: DIGITAL HEALTH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 282 TABLE 258 LATIN AMERICA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 282 TABLE 259 LATIN AMERICA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 260 LATIN AMERICA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 261 LATIN AMERICA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 262 LATIN AMERICA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 263 LATIN AMERICA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 284 TABLE 264 LATIN AMERICA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 285 TABLE 265 LATIN AMERICA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 285 TABLE 266 LATIN AMERICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 267 LATIN AMERICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 268 BRAZIL: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 287 TABLE 269 BRAZIL: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 270 BRAZIL: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 271 BRAZIL: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 272 BRAZIL: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 273 BRAZIL: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 289 TABLE 274 BRAZIL: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 290 TABLE 275 BRAZIL: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 290 TABLE 276 BRAZIL: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 277 BRAZIL: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 278 MEXICO: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 292 TABLE 279 MEXICO: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 280 MEXICO: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 281 MEXICO: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 282 MEXICO: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 283 MEXICO: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 294 TABLE 284 MEXICO: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 295 TABLE 285 MEXICO: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 295 TABLE 286 MEXICO: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 287 MEXICO: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 288 REST OF LATIN AMERICA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 297 TABLE 289 REST OF LATIN AMERICA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 290 REST OF LATIN AMERICA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 291 REST OF LATIN AMERICA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 292 REST OF LATIN AMERICA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 293 REST OF LATIN AMERICA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 299 TABLE 294 REST OF LATIN AMERICA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 300 TABLE 295 REST OF LATIN AMERICA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 300 TABLE 296 REST OF LATIN AMERICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 297 REST OF LATIN AMERICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 298 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 302 TABLE 299 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 303 TABLE 300 MIDDLE EAST & AFRICA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 301 MIDDLE EAST & AFRICA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 302 MIDDLE EAST & AFRICA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 303 MIDDLE EAST & AFRICA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 304 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 305 TABLE 305 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 305 TABLE 306 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 306 TABLE 307 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 308 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 309 GCC: DIGITAL HEALTH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 307 TABLE 310 GCC: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 308 TABLE 311 GCC: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 312 GCC: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 313 GCC: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 314 GCC: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 315 GCC: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 310 TABLE 316 GCC: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 310 TABLE 317 GCC: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 311 TABLE 318 GCC: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 319 GCC: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 320 SAUDI ARABIA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 312 TABLE 321 SAUDI ARABIA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 322 SAUDI ARABIA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 323 SAUDI ARABIA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 324 SAUDI ARABIA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 325 SAUDI ARABIA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 315 TABLE 326 SAUDI ARABIA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 315 TABLE 327 SAUDI ARABIA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 316 TABLE 328 SAUDI ARABIA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 329 SAUDI ARABIA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 330 UAE: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 318 TABLE 331 UAE: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 332 UAE: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 333 UAE: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 334 UAE: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 335 UAE: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 320 TABLE 336 UAE: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 320 TABLE 337 UAE: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 321 TABLE 338 UAE: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 339 UAE: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 340 REST OF GCC: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 322 TABLE 341 REST OF GCC: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 342 REST OF GCC: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 343 REST OF GCC: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 344 REST OF GCC: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 345 REST OF GCC: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 325 TABLE 346 REST OF GCC: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 325 TABLE 347 REST OF GCC: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 326 TABLE 348 REST OF GCC: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 349 REST OF GCC: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 350 SOUTH AFRICA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 327 TABLE 351 SOUTH AFRICA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 352 SOUTH AFRICA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 353 SOUTH AFRICA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 354 SOUTH AFRICA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 355 SOUTH AFRICA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 330 TABLE 356 SOUTH AFRICA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 330 TABLE 357 SOUTH AFRICA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 331 TABLE 358 SOUTH AFRICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 359 SOUTH AFRICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 360 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 332 TABLE 361 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 362 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 363 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 334 TABLE 364 REST OF MIDDLE EAST & AFRICA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 334 TABLE 365 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 335 TABLE 366 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 335 TABLE 367 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 336 TABLE 368 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 369 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 370 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL HEALTH MARKET, JANUARY 2022–JULY 2025 337 TABLE 371 DIGITAL HEALTH MARKET: DEGREE OF COMPETITION 341 TABLE 372 DIGITAL HEALTH MARKET: REGION FOOTPRINT 348 TABLE 373 DIGITAL HEALTH MARKET: OFFERING FOOTPRINT 349 TABLE 374 DIGITAL HEALTH MARKET: DISEASE FOOTPRINT 350 TABLE 375 DIGITAL HEALTH MARKET: USE CASE FOOTPRINT 351 TABLE 376 DIGITAL HEALTH MARKET: END USER FOOTPRINT 352 TABLE 1 DIGITAL HEALTH MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 355 TABLE 377 DIGITAL HEALTH MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION 355 TABLE 378 DIGITAL HEALTH MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY DISEASE 356 TABLE 379 DIGITAL HEALTH MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 356 TABLE 380 DIGITAL HEALTH MARKET: DEALS, JANUARY 2022–JULY 2025 357 TABLE 381 DIGITAL HEALTH MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 358 TABLE 382 MEDTRONIC: COMPANY OVERVIEW 359 TABLE 383 MEDTRONIC: PRODUCTS OFFERED 360 TABLE 384 MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 362 TABLE 385 MEDTRONIC: DEALS, JANUARY 2022–JULY 2025 363 TABLE 386 MEDTRONIC: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 364 TABLE 387 ABBOTT: COMPANY OVERVIEW 366 TABLE 388 ABBOTT: PRODUCTS OFFERED 367 TABLE 389 ABBOTT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 368 TABLE 390 ABBOTT: DEALS, JANUARY 2022–JULY 2025 369 TABLE 391 DEXCOM, INC.: COMPANY OVERVIEW 371 TABLE 392 DEXCOM, INC.: PRODUCTS OFFERED 372 TABLE 393 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 372 TABLE 394 DEXCOM, INC.: DEALS, JANUARY 2022–JULY 2025 373 TABLE 395 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 375 TABLE 396 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 376 TABLE 397 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 378 TABLE 398 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–JULY 2025 378 TABLE 399 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2022–JULY 2025 379 TABLE 400 FITBIT, INC.: COMPANY OVERVIEW 380 TABLE 401 FITBIT, INC.: PRODUCTS OFFERED 381 TABLE 402 FITBIT, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 382 TABLE 403 FITBIT, INC.: DEALS, JANUARY 2022–JULY 2025 382 TABLE 404 OMRON HEALTHCARE, INC.: COMPANY OVERVIEW 384 TABLE 405 OMRON HEALTHCARE, INC.: PRODUCTS OFFERED 385 TABLE 406 OMRON HEALTHCARE, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 387 TABLE 407 OMRON HEALTHCARE, INC., JANUARY 2022–JULY 2025 387 TABLE 408 APPLE, INC.: COMPANY OVERVIEW 389 TABLE 409 APPLE, INC.: PRODUCTS OFFERED 390 TABLE 410 APPLE, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 391 TABLE 411 APPLE, INC.: DEALS, JANUARY 2022–JULY 2025 392 TABLE 412 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 393 TABLE 413 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 394 TABLE 414 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 395 TABLE 415 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–JULY 2025 396 TABLE 416 MASIMO: COMPANY OVERVIEW 397 TABLE 417 MASIMO: PRODUCTS OFFERED 398 TABLE 418 MASIMO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 399 TABLE 419 MASIMO: DEALS, JANUARY 2022–JULY 2025 400 TABLE 420 TELADOC HEALTH, INC.: COMPANY OVERVIEW 401 TABLE 421 TELADOC HEALTH, INC.: PRODUCTS OFFERED 402 TABLE 422 TELADOC HEALTH, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 403 TABLE 423 TELADOC HEALTH, INC.: DEALS, JANUARY 2022–JULY 2025 404 TABLE 424 AMERICAN WELL: COMPANY OVERVIEW 406 TABLE 425 AMERICAN WELL: PRODUCTS OFFERED 407 TABLE 426 AMERICAN WELL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 408 TABLE 427 AMERICAN WELL: DEALS, JANUARY 2022–JULY 2025 408 TABLE 428 AMERICAN WELL: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 409 TABLE 429 HIMS & HERS HEALTH, INC.: COMPANY OVERVIEW 410 TABLE 430 HIMS & HERS HEALTH, INC.: PRODUCTS OFFERED 411 TABLE 431 HIMS & HERS HEALTH, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 412 TABLE 432 HIMS & HERS HEALTH, INC.: DEALS, JANUARY 2022–JULY 2025 413 TABLE 433 HEADSPACE: COMPANY OVERVIEW 414 TABLE 434 HEADSPACE: PRODUCTS OFFERED 414 TABLE 435 HEADSPACE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 415 TABLE 436 HEADSPACE: DEALS, JANUARY 2022–JULY 2025 416 TABLE 437 NOOM, INC.: COMPANY OVERVIEW 417 TABLE 438 NOOM, INC.: PRODUCTS OFFERED 417 TABLE 439 NOOM, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 418 TABLE 440 NOOM, INC.: DEALS, JANUARY 2022–JULY 2025 418 TABLE 441 CEREBRAL INC.: COMPANY OVERVIEW 420 TABLE 442 CEREBRAL INC.: PRODUCTS OFFERED 420 TABLE 443 CEREBRAL INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 421 TABLE 444 CEREBRAL INC.: DEALS, JANUARY 2022–JULY 2025 421 TABLE 445 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 423 TABLE 446 EPIC SYSTEMS CORPORATION: PRODUCTS OFFERED 423 TABLE 447 EPIC SYSTEM CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 424 TABLE 448 EPIC SYSTEM CORPORATION: DEALS, JANUARY 2022–JULY 2025 424 TABLE 449 OMADA HEALTH INC.: COMPANY OVERVIEW 425 TABLE 450 OMADA HEALTH INC.: PRODUCTS OFFERED 426 TABLE 451 OMADA HEALTH INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 427 TABLE 452 OMADA HEALTH INC.: DEALS, JANUARY 2022–JULY 2025 428 TABLE 453 ORACLE: COMPANY OVERVIEW 429 TABLE 454 ORACLE: PRODUCTS OFFERED 430 TABLE 455 ORACLE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 431 TABLE 456 ORACLE: DEALS, JANUARY 2022–JULY 2025 431 TABLE 457 CLICK THERAPEUTICS, INC.: COMPANY OVERVIEW 432 TABLE 458 CLICK THERAPEUTICS, INC.: PRODUCTS OFFERED 432 TABLE 459 CLICK THERAPEUTICS, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 433 TABLE 460 CLICK THERAPEUTICS, INC.: DEALS, JANUARY 2022–JULY 2025 434 TABLE 461 WELLDOC, INC.: COMPANY OVERVIEW 435 TABLE 462 WELLDOC, INC.: PRODUCTS OFFERED 435 TABLE 463 WELLDOC, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 436 TABLE 464 WELLDOC, INC.: DEALS, JANUARY 2022–JULY 2025 436 TABLE 465 EVERLYWELL: COMPANY OVERVIEW 437 TABLE 466 EVERLYWELL: PRODUCTS OFFERED 437 TABLE 467 EVERLYWELL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 438 TABLE 468 EVERLYWELL: DEALS, JANUARY 2022–JULY 2025 439 FIGURE 1 RESEARCH DESIGN 43 FIGURE 2 PRIMARY SOURCES 46 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 48 FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 49 FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION 50 FIGURE 6 DIGITAL HEALTH MARKET: REVENUE ESTIMATION APPROACH 51 FIGURE 7 BOTTOM-UP APPROACH: END USER SPENDING ON DIGITAL HEALTH 53 FIGURE 8 TOP-DOWN APPROACH 54 FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 56 FIGURE 10 DIGITAL HEALTH MARKET: CAGR PROJECTIONS 57 FIGURE 11 DATA TRIANGULATION METHODOLOGY 58 FIGURE 12 DIGITAL HEALTH MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION) 61 FIGURE 13 DIGITAL HEALTH MARKET, BY DISEASE, 2025 VS. 2030 (USD MILLION) 62 FIGURE 14 DIGITAL HEALTH MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 63 FIGURE 15 GEOGRAPHICAL SNAPSHOT OF DIGITAL HEALTH MARKET 64 FIGURE 16 RISING FOCUS ON PATIENT-CENTRIC HEALTHCARE SOLUTIONS TO DRIVE MARKET 66 FIGURE 17 HEALTHCARE PROVIDERS HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2024 67 FIGURE 18 MARKET IN INDIA TO REGISTER HIGHEST GROWTH 68 FIGURE 19 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 69 FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH BETWEEN 2025 & 2030 69 FIGURE 21 DIGITAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 70 FIGURE 22 SMARTPHONE USERS WORLDWIDE, 2016–2027 (BILLION) 71 FIGURE 23 GERIATRIC POPULATION, BY REGION, 2010–2030 (% OF TOTAL POPULATION) 72 FIGURE 24 DIGITAL HEALTH MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 80 FIGURE 25 DIGITAL HEALTH MARKET: ECOSYSTEM ANALYSIS 83 FIGURE 26 DIGITAL HEALTH MARKET: SUPPLY CHAIN ANALYSIS (2024) 84 FIGURE 27 DIGITAL HEALTH MARKET: PORTER’S FIVE FORCES ANALYSIS 106 FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 108 FIGURE 29 KEY BUYING CRITERIA FOR DIGITAL HEALTH OFFERINGS 109 FIGURE 30 PATENT PUBLICATION TRENDS IN DIGITAL HEALTH MARKET, 2015–2025 110 FIGURE 31 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR “DIGITAL HEALTH” PATENTS (JANUARY 2015–MARCH 2025) 111 FIGURE 32 MAJOR PATENTS IN DIGITAL HEALTH MARKET (JANUARY 2015–MARCH 2025) 112 FIGURE 33 INVESTMENT LANDSCAPE AND FUNDING SCENARIO, 2025 (USD MILLION) 117 FIGURE 34 IMPORTS OF PRODUCTS UNDER HSN CODE 8518, BY COUNTRY, 2024 (USD THOUSAND) 118 FIGURE 35 EXPORTS OF PRODUCTS UNDER HSN CODE 8518, BY COUNTRY, 2024 (USD THOUSAND) 118 FIGURE 36 IMPORTS OF PRODUCTS UNDER HSN CODE 9021, BY COUNTRY, 2024 (USD THOUSAND) 119 FIGURE 37 EXPORTS OF PRODUCTS UNDER HSN CODE 9021, BY COUNTRY, 2024 (USD THOUSAND) 119 FIGURE 38 IMPORTS OF PRODUCTS UNDER HSN CODE 9022, BY COUNTRY, 2024 (USD THOUSAND) 120 FIGURE 39 EXPORTS OF PRODUCTS UNDER HSN CODE 9022, BY COUNTRY, 2024 (USD THOUSAND) 120 FIGURE 40 IMPORTS OF PRODUCTS UNDER HSN CODE 9018, BY COUNTRY, 2024 (USD THOUSAND) 121 FIGURE 41 EXPORTS OF PRODUCTS UNDER HSN CODE 9018, BY COUNTRY, 2024 (USD THOUSAND) 121 FIGURE 42 MARKET POTENTIAL OF AI/GENERATIVE AI DIGITAL HEALTH ACROSS INDUSTRIES 124 FIGURE 43 NORTH AMERICA: DIGITAL HEALTH MARKET SNAPSHOT 193 FIGURE 44 ASIA PACIFIC: DIGITAL HEALTH MARKET SNAPSHOT 246 FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN DIGITAL HEALTH MARKET, 2020–2024 (USD MILLION) 340 FIGURE 46 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DIGITAL HEALTH MARKET (2024) 341 FIGURE 47 DIGITAL HEALTH MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 343 FIGURE 48 EV/EBITDA OF KEY VENDORS, 2025 344 FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025 345 FIGURE 50 DIGITAL HEALTH MARKET: COMPANY EVALUATION MATRIX, 2024 346 FIGURE 51 DIGITAL HEALTH MARKET: COMPANY FOOTPRINT 347 FIGURE 52 DIGITAL HEALTH MARKET: STARTUP/SME EVALUATION MATRIX, 2024 354 FIGURE 53 MEDTRONIC: COMPANY SNAPSHOT (2025) 360 FIGURE 54 ABBOTT: COMPANY SNAPSHOT (2024) 367 FIGURE 55 DEXCOM, INC.: COMPANY SNAPSHOT (2024) 371 FIGURE 56 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 376 FIGURE 57 GOOGLE: COMPANY SNAPSHOT (2024) 381 FIGURE 58 OMRON HEALTHCARE, INC.: COMPANY SNAPSHOT (2023) 385 FIGURE 59 APPLE, INC.: COMPANY SNAPSHOT (2024) 390 FIGURE 60 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 394 FIGURE 61 MASIMO: COMPANY SNAPSHOT (2024) 398 FIGURE 62 TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2024) 402 FIGURE 63 AMERICAN WELL: COMPANY SNAPSHOT (2024) 407 FIGURE 64 HIMS & HERS HEALTH, INC.: COMPANY SNAPSHOT (2024) 411 FIGURE 65 OMADA HEALTH INC.: COMPANY SNAPSHOT (2024) 426 FIGURE 66 ORACLE: COMPANY SNAPSHOT (2025) 430